23. Substance Addiction and Gastrointestinal Malignancy

  1. Norman S. Miller Clinical Professor Courtesy Professor2,3 and
  2. Mark S. Gold Chairman4
  1. Jason T. Hedrick and
  2. James R. Ouellette

Published Online: 26 JUL 2010

DOI: 10.1002/9780470710449.ch23

Addictive Disorders in Medical Populations

Addictive Disorders in Medical Populations

How to Cite

Hedrick, J. T. and Ouellette, J. R. (2010) Substance Addiction and Gastrointestinal Malignancy, in Addictive Disorders in Medical Populations (eds N. S. Miller and M. S. Gold), Wiley-Blackwell, Chichester, UK. doi: 10.1002/9780470710449.ch23

Editor Information

  1. 2

    Department of Medicine, Michigan State University, East Lansing, Michigan 48824, USA

  2. 3

    Department of Psychiatry, The University of Florida, Gainesville, FL 32611, USA

  3. 4

    College of Medicine, Departments of Psychiatry, Neuroscience, Anesthesiology, Community Health & Family Medicine, University of Florida College of Medicine and McKnight Brain Institute, Gainesville, FL 32611, USA

Author Information

  1. Department of Surgery, Division of Surgical Oncology, Wright State University, Dayton, OH, USA

Publication History

  1. Published Online: 26 JUL 2010
  2. Published Print: 27 AUG 2010

ISBN Information

Print ISBN: 9780470740330

Online ISBN: 9780470710449



  • Substance addiction and gastrointestinal malignancy;
  • Identifying substance addiction;
  • Treating cancer pain;
  • Role of Addiction in Specific GI Malignancies;
  • Squamous Cell Carcinoma (SCC) or Adenocarcinoma (AC);
  • Nonsolid organ malignancies (esophagus, stomach, colorectal);
  • gastroesophageal reflux disease (GERD);
  • Effect of smoking and alcohol on chemotherapy;
  • fecal occult blood testing (FOBT);
  • Solid organ GI malignancy (liver, pancreas)


This chapter contains sections titled:

  • Introduction

  • Role of Addiction in Specific GI Malignancies

  • Palliative Care Issues

  • References